117 related articles for article (PubMed ID: 20417562)
21. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
Walunas TL; Bluestone JA
J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
[TBL] [Abstract][Full Text] [Related]
22. Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo.
Rudolph M; Hebel K; Miyamura Y; Maverakis E; Brunner-Weinzierl MC
J Immunol; 2011 May; 186(10):5580-9. PubMed ID: 21478403
[TBL] [Abstract][Full Text] [Related]
23. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells.
Hoff H; Knieke K; Cabail Z; Hirseland H; Vratsanos G; Burmester GR; Jorch G; Nadler SG; Bröker B; Hebel K; Brunner-Weinzierl MC
J Immunol; 2009 May; 182(9):5342-51. PubMed ID: 19380781
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin ligases and the immune response.
Liu YC
Annu Rev Immunol; 2004; 22():81-127. PubMed ID: 15032575
[TBL] [Abstract][Full Text] [Related]
25. The E3 ubiquitin ligase Itch is required for B-cell development.
Liu X; Zhang Y; Wei Y; Wang Z; Zhu G; Fang Y; Zhai B; Xu R; Han G; Chen G; Xiao H; Hou C; Shen B; Li Y; Ma N; Wang R
Sci Rep; 2019 Jan; 9(1):421. PubMed ID: 30674954
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.
Dillon TJ; Carey KD; Wetzel SA; Parker DC; Stork PJ
Mol Cell Biol; 2005 May; 25(10):4117-28. PubMed ID: 15870282
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
Azakir BA; Angers A
Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
[TBL] [Abstract][Full Text] [Related]
29. The role of tyrosine phosphorylation and PTP-1C in CTLA-4 signal transduction.
Chambers CA; Allison JP
Eur J Immunol; 1996 Dec; 26(12):3224-9. PubMed ID: 8977326
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.
Srahna M; Van Grunsven LA; Remacle JE; Vandenberghe P
Immunology; 2006 Mar; 117(3):396-401. PubMed ID: 16476059
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
32. CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin.
Hegel JK; Knieke K; Kolar P; Reiner SL; Brunner-Weinzierl MC
Eur J Immunol; 2009 Mar; 39(3):883-93. PubMed ID: 19224637
[TBL] [Abstract][Full Text] [Related]
33. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
[TBL] [Abstract][Full Text] [Related]
34. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
35. Is CTLA-4 a master switch for peripheral T cell tolerance?
Bluestone JA
J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
[TBL] [Abstract][Full Text] [Related]
36. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
37. MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4).
Stohl W; Xu D; Kim KS; David CS; Allison JP
Int Immunol; 2004 Jul; 16(7):895-904. PubMed ID: 15136557
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin ligases in T cell activation and autoimmunity.
Zhang J
Clin Immunol; 2004 Jun; 111(3):234-40. PubMed ID: 15183144
[TBL] [Abstract][Full Text] [Related]
39. CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells.
Stojanovic A; Fiegler N; Brunner-Weinzierl M; Cerwenka A
J Immunol; 2014 May; 192(9):4184-91. PubMed ID: 24688023
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4 negative signaling via lipid rafts: A new perspective.
Rudd CE; Martin M; Schneider H
Sci STKE; 2002 Apr; 2002(128):pe18. PubMed ID: 11972356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
